Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHB1950749	阿伐斯汀胶囊	acrivastine	Capsule	Chemical Drugs	Supplementary Application	2019-11-05	重庆华邦制药有限公司	Chongqing Huapont Pharmaceutical Co Ltd	Certificate Issued	2020-09-02	view
H20020102	阿伐斯汀胶囊	acrivastine	Capsule	Chemical Drugs	Import Drug Application	2002-04-27	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2003-04-08	view
CYHS0690318	阿伐斯汀胶囊	acrivastine	Capsule	Chemical Drugs(6)	Generic Drug	2006-07-06	重庆华邦制药股份有限公司	Chongqing Huapont Pharmaceutical Co Ltd	Certificate Issued	2008-05-30	view
CYHS0502529	阿伐斯汀胶囊	acrivastine	Capsule	Chemical Drugs(6)	Generic Drug	2005-04-27	重庆华邦制药股份有限公司	Chongqing Huapont Pharmaceutical Co Ltd	Certificate Issued	2005-12-22	view
CXHL0700318	复方阿伐斯汀胶囊		Capsule	Chemical Drugs(3.2)	New Drug Application	2007-11-19	合肥合源医药科技有限公司	Hefei Heyuan Pharmaceutical Technology Co Ltd	Certificate Issued	2009-02-25	view